Conversations on Twitter :
-
Biotech vs. Tech by the Numbers: Recent tech IPOs have lost more market cap than 10x the entire value of recent biotech IPOs
Input from venture insiders @lifescivc, @daphnezohar, @bobmorevc and others - Were we misled? As FDA rejects Halozyme's immune deficiency Tx, insiders question the company's transparency
@FierceBiotech: RIP: After long illness, Genta finally opts to liquidate. News | Follow @FierceBiotech
@JohnCFierce: Bristol's bad, awful, not very good day. Pensions exec charged with insider trading, via Bloomberg. And it's still early. More | Follow @JohnCFierce
@RyanMFierce: A Google search for scientific experts? AstraZeneca adopts search engine for scientists from David Steinberg's Knode. Article | Follow @RyanMFierce
> GlaxoSmithKline wasted no time pussyfooting around Human Genome Sciences, now that it owns the place. Glaxo swept into its newly acquired company and swept out almost all of its leadership. GSK ($GSK) veterans are taking the top three executive spots at HGS, The Washington Post reports. Deirdre Connelly will take the helm as president and CEO, replacing H. Thomas Watkins, who's been running the company since 2004. Connelly has been running Glaxo's North American pharma business. Story
> London-based drug giant AstraZeneca ($AZN) has headlined a group of early users of Boston-based startup Knode's search engine of sorts for finding life sciences experts and their digital content, becoming the first Big Pharma revealed as an adopter of the web-based software. Story
> Hemispherx ($HEB) says it has filed a response to the FDA's 2009 CRL on its NDA for Ampligen to treat chronic fatigue syndrome. Release
> Map Pharmaceuticals ($MAPP) is raising $52 million to market its migraine drug after a hoped-for approval. Story
Pharma News
@FiercePharma: Watson got FDA nod for its Pulmicort knockoff. Patent fight with AstraZeneca pending, so no launch yet. Report | Follow @FiercePharma
> Gilead inks low-cost HIV drug deal with generics makers. News
> Sanofi, Otsuka amp up their Turkish ambitions. Story
> Glass Lewis stands up for Forest's board slate. Article
@FierceMedDev: The $3.8B deal is done. Hologic wrapped up its bid to acquire Gen-Probe. Release | Follow @FierceMedDev
@MarkHFierce: Regulators in Singapore lowered import fees for blood pressure monitors and hearing aids. More | Follow @MarkHFierce
@DamianFierce: Covidien has opened up its $45M R&D shop in Shanghai. News | Follow @DamianFierce
> CareFusion hit with Class I recall of infusion pump component. News
> Becton, Dickinson trims expectations after Q3 loss. More
Vaccines News
> Old whooping cough vax more effective than new. News
> AstraZeneca wins Fluenz contract in U.K. Article
> Survey: U.S. females fail to finish Merck and GSK HPV shots. More
> NIH awards $5M for heroin addiction, AIDS vaccine. News
> Alnylam gets $3.2M milestone from GSK for vax tech. Story
Pharma Manufacturing News
> Hospira CEO Ball says it's getting 'gators' under control. Report
> Rexam eyes factory growth, despite lagging healthcare sales. More
> CMC nabs Xoma's Bay Area plant. Article
And Finally… New research indicates that coffee may help Parkinson's patients to control their movements. Release